2025 ACMG Genetics and Genomics Review Course
Tracking # 20-1289337
Price not reported
There are no ratings for this course
Learn moreCourse overview
Packed with content to pass the ABMGG Board Exam or Take the Couse as a Refresher. The 2025 ACMG Genetics and Genomics Review Course will be offered via the ACMG Genetics Academy. Topics include exam preparation and lectures that cover a broad range of genetic and genomic topics presented by recognized experts in the field. See the list below. Registration is open with live Q and A sessions June 2 through 6. Need to do it all in a week. We have a schedule for you too. This course consists of the following 5 Live Zoom Q and A Sessions with Faculty and a Live Exam Workshop A Pre Exam which is required 20 Recorded Lectures PDFs of slides provided ACMG Board Review QBank with over 600 questions. Build your own exam, Test, Retake, Rebuild Electronic Syllabus Exam Book by Sections
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
Accredited Continuing Education Financial Disclosure
The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.
ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.